Tag: Generics

Kent Bernard, Sep 30, 2010 By its decision of July 1, 2010 in AstraZeneca the General Court upheld the decision of the European Commission that...

Marc van der Waude, Marc van der Waude, Nov 01, 2009 The purpose of this contribution is to explore the status types that settlements and...

This article is part of a Chronicle. See more from this Chronicle Charlene Jones, Aidan Synnott, Nov 25, 2009 In October 2009, the United States Court...

Anne Layne-Farrar, Nov 01, 2009 This article begins by laying out a simple framework that makes obvious the incentives at play in generic drug entry,...

Michael Kades, Nov 01, 2009 Arguably, the most important debate in antitrust jurisprudence involves pay-for-delay patent settlements in which the brand company pays the generic...

Elai Katz, William Rooney, Nov 01, 2009 Two bills seeking to ban reverse-payment agreements are currently pending in Congress, and the European Commission has declared...

This article is part of a Chronicle. See more from this Chronicle Patrick Harrison, Kristina Nordlander, Aug 13, 2009 On July 8, 2009, the European Commission's...

This article is part of a Chronicle. See more from this Chronicle Richard Epstein, Mar 26, 2009 The purpose of this brief essay is to address...

This article is part of a Chronicle. See more from this Chronicle Luc Gyselen, Feb 26, 2009 This article will focus on the Commission's antitrust enforcement...

This article is part of a Chronicle. See more from this Chronicle David Hull, Feb 25, 2009 Much of the discussion at the time of the...